Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.16 USD | -9.41% | -8.61% | +9.03% |
09/05 | Stifel Adjusts Price Target on C4 Therapeutics to $14 From $13, Maintains Buy Rating | MT |
08/05 | C4 Therapeutics Shares Decline as Q1 Revenue Misses Estimates | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.03% | 42Cr | |
+17.96% | 4.5TCr | |
+1.17% | 4.26TCr | |
+46.68% | 4.18TCr | |
-4.27% | 2.9TCr | |
+11.42% | 2.61TCr | |
-21.39% | 1.9TCr | |
+4.86% | 1.28TCr | |
+27.29% | 1.21TCr | |
-3.50% | 1.18TCr |
- Stock Market
- Equities
- CCCC Stock
- News C4 Therapeutics, Inc.
- HC Wainwright Adjusts Price Target on C4 Therapeutics to $35 From $63, Reiterates Buy Rating